“Non-Profit Suing CBC for Defamation Over Series of Articles”, Calgary Herald

This August 18, 2017 article (2 minute read) by Kevin Martin of the Calgary Herald, “Non-profit suing CBC for defamation over series of articles”, shares the details of a law suit brought by Pure North S’Energy Foundation (“Pure North”), against the CBC for inaccurate and defamatory reporting about the organization. Pure North is a non-profit preventative wellness organization co-founded by natural health enthusiast, philanthropist, and former Calgary Flames owner, Allan Markin.

“Pure North has repeatedly requested that the CBC change its reporting to publicize accurate facts, and Pure North has supported its requests with multiple pieces of scientific research and practice guidelines for medical practitioners which supports Pure North’s practices and operations”, the article reports.

It is no secret that in today’s fast-paced and heavily populated media industry, journalists face challenges in carrying out the due diligence required for accurate and unbiased press. Access to the most up-to-date information is demanded around the clock and, with that, for some media outlets, comes less scrutiny in research and reporting. Significant skew factors also include politically right, left or ideologically driven components of a news medium.

When it comes to issues surrounding natural health, CBC has a reputation for engaging in “yellow journalism” to perpetuate the misconceptions and myths surrounding NHPs, natural treatments, their safety and effectiveness. A good example is the inaccuracy and manufactured distortions written regarding the death of David and Collet Stephan’s son Ezekiel. What has been reported seriously questions these journalist’s processes and competence as well as both their value and critical judgments.

CBC’s the Fifth Estate episode “Magic Pills” debacle in 2015, and their eventual retraction, is another example of their lack of journalistic integrity. Shawn Buckley wrote commentary on this.

Like NHPPA, Allan Markin, does not eschew conventional medical treatments. Rather, he advocates for and supports freedom to choose natural alternatives. Read more about Allan Markin’s work and philanthropy through Pure North.


“105-Year-Old Doctor Offers Advice on How to Live Longer and Be Happy Every Day”, The Hearty Soul

We’d like to add take your vitamins, of course! The Hearty Soul recently posted a tribute (4 minute read) to Dr. Shigeaki Hinohara, “105-Year-Old Doctor Offers Advice on How to Live Longer and Be Happy Every Day”. It shares with us 10 thoughtful lessons on his perspective in getting the most out of life. From your experiences, what advice would you add to Dr. Hinohara’s for a long and happy life?


“Not Taking Your Medication? These New Digital Pills Will Allow Doctors to Keep Track of Your Adherence”, National Post

Medical breakthrough or biological surveillance? In this November 14, 2017 National Post article (2.5 minute read) written by Caroline Chen, “Not taking your medication? These new digital pills will allow doctors to keep track of your adherence”, we learn of a new version of Otsuka Pharmaceutical’s Abilify drug which has a built-in sensor to allow doctors to monitor whether or not their patients are complying with their prescription. Abilify is used to treat depression, bipolar disorder and schizophrenia.

The New York Times ran a story (9.5 minute read) by Pam Belluck, the day before, on November 13, 2017, “First Digital Pill Approved to Worries About Biomedical ‘Big Brother’”.

Both Chen and Belluck, among other health and science writers, include intel gathering and ethical considerations. Lucia Savage, chief privacy and regulatory officer with Omada Health Inc. states, “It creates a looking-over-your-shoulder effect. Patients who are prescribed the product, called Abilify MyCite, have to agree that their physicians can see the data. They can also choose whether or not to share information with caregivers, such as family members. Otsuka Pharmaceutical and certain insurers also plan to gather anonymized, aggregated data from patients who consent.”

Dr. Peter Kramer, a psychiatrist and the author of “Listening to Prozac,” raised concerns about “packaging a medication with a tattletale.” While ethical for “a fully competent patient who wants to lash him or herself to the mast,” he said, “‘digital drug’ sounds like a potentially coercive tool.”

At the moment, taking this digital pill is voluntary but it raises questions like, aside from monitoring compliance, what other intentions are behind the gathering of the “anonymized, aggregated data”? There is no indication of what it includes. How does the sensor’s signal interfere with the human body’s natural electrical currents? If the pills are not taken, what are the consequences for the patient and how are they handled? Are patients with severe mental illness like bipolar disorder or schizophrenia in a position to provide legal consent to have their doctors, drug companies and insurers monitor their compliance? This could be the beginning of a trend by drug companies and researchers to produce a broad and rapid use of trackable medicines for behaviour modification.



Ontario Raw Milk Farmer Convicted and Sentenced for Protecting Private Property and Farm Owners’ Rights

Chances are slim any of you spent the weekend in jail. At 6:00 pm Friday November 10, 2017 raw milk farmer, food rights advocate and social activist Michael Schmidt entered the Central North Correctional Centre, a maximum security prison in Penetanguishene, Ontario. It is both a remand facility and one where time is served for a range of minor offenses and serious crimes. For Michael, it was the first of a 60 day “rehabilitation and deterrence” sentence to be served on weekends.

NHPPA connected with Michael before his 3 hour drive from farm to prison…

Read excerpts from our conversation with Michael


Acid Reflux Drug Linked to More than Doubled Risk of Stomach Cancer – study, The Guardian

This October 31, 2017 article from The Guardian [UK] (2.5 minute read), “Acid reflux drug linked to more than doubled risk of stomach cancer – study”, reveals the results of research conducted by the University of Hong Kong and University College London on the long-term use of Proton Pump Inhibitor (PPI) medications for conditions associated with acid reflux.

The article notes, “Daily use of PPIs was associated with a risk of developing the illness that was more than four times higher (4.55) than those who used it weekly. Similarly, when the drug was used for more than a year, the risk of developing stomach cancer rose five-fold, and as high as eight-fold after three or more years, the findings showed.”

Responding to the study, Stephen Evans, professor of pharmacoepidemiology with the London School of Hygiene and Tropical Medicine, states, “The most plausible explanation for the totality of evidence on this is that those who are given PPIs, and especially those who continue on them long-term, tend to be sicker in a variety of ways than those for whom they are not prescribed.”


“Throat Spray Proven Effective for Fighting Cold and Flu”, Winnipeg Free Press

This Winnipeg Free Press article (2.5 minute read), “Throat spray proven effective for fighting cold, flu”, published on November 2, 2017, shares the results of the University of Manitoba Richardson Centre’s study on the effectiveness and safety of InnoTech Nutrition’s Colflex throat spray.

“In the lab, we found this product halted the incubation of staph, strep, e-coli and salmonella bacteria in less than 30 minutes,” Dr. Peter Jones said. “Moreover, our double-blind, randomized clinical trial showed Colflex had no effect on the glucose levels (blood sugar), lipids (cholesterol), or liver enzymes of people who took the supplement over a period of four weeks.”

InnoTech’s CEO, Wayne Friesen, notes in the article that NHPs make health claims for benefits but are often not “put to the test”. While there may not be a vast database of double-blind, randomized, controlled clinical trials on NHPs, there are well documented sources of anecdotal and traditional evidence with decidedly positive and safe outcomes. Often for centuries and, in some cases, for millennia. The growing public demand for a natural health product with longstanding results of efficacy is also a test that many without DBRCTs continue to pass.

Innotech’s Colflex was supported by contemporary science confirming widely established knowledge in natural medicines and practices about the power of essential spice oils.

Unfortunately, the same cannot be said about the safety outcomes of many pharmaceutical cold and flu medications that do go through the same gold standard testing process. For example, acetaminophen, often used for the treatment of colds and reduction of fevers related to the flu, is one of the most common causes of liver failure in the US and Canada.



Everyone Deserves Choice